The 411 on Sleep Apnea and How You Can Beat It
A new report suggests that sleep apnea may have contributed to the death of Supreme Court Justice Antonin Scalia.
Was sleep apnea a factor in the death of Antonin Scalia?
The dangers of sleep apnea
Valeant to Restate Results, Shares Fall
Valeant Pharmaceuticals said it would restate its financial results for 2014 and 2015 after identifying some sales to Philidor that should have been recognized when products were dispensed to patients.
Highmark to reduce what it pays to doctors under ObamaCare plans
ObamaCare's impact on health care costs
The technological advances to treat cancer
New cancer treatments
IBM to Buy Data Company Truven Health Analytics for $2.6 Billion
International Business Machines Corp said it would buy Truven Health Analytics, a provider of cloud-based healthcare data, for $2.6 billion, the company's fourth major health-related acquisition since launching the Watson Health unit in April last year.
IBM to Acquire Truven Health Analytics for $2.6B
International Business Machines said on Thursday it plans to acquire Truven Health Analytics, a provider of healthcare data and analytics, for $2.6 billion, marking its fourth major health data-related deal in the past year.
Are scientists on the cusp of finding a cure for cancer?
Cure for cancer?
Potential breakthrough in the treatment of cancer?
Cancer breakthrough?
Is your employer tracking your health?
Tracking employee health
The potential breakthrough in the fight against cancer
Cancer breakthrough
Community Health Stock Slumps After Surprise Loss, Rivals Also Hit
Community Health Systems shares were under pressure, after the No.2 U.S. for-profit hospital operator posted a surprise quarterly loss Monday after the close.
Regeneron Pharma Expects Slowing Eylea Sales, Shares Slip
Regeneron Pharmaceuticals reported a weaker-than-expected profit for the first time in four quarters and forecast slowing sales growth for its blockbuster eye drug this year.
Patient speaks about Turing drug price hike
Turing drug price hike
Zika virus impacting Americans' travel plans
Zika discouraging travel
CDC takes on fetal alcohol syndrome with new warning
Zika fears grow
Concerns about Zika virus justified?
Latest on the Zika virus
Edwards Lifesciences Boosts Full-Year Profit Outlook
Edwards Lifesciences raised its full-year earnings forecast, anticipating stronger sales of its artificial heart valves.
Pfizer's 4Q Earnings Beat, Outlook Misses
Dow component Pfizer reported an adjusted 4Q profit of $0.53 per share, topping the estimate for $0.52. Revenue for the drugmaker came in at $14 billion, also beating the estimate for $13.56 billion.
Abbott Labs to Buy Alere for $5.8B
Drugmaker Abbott Laboratories said it would acquire Alere for $5.8 billion to boost its global diagnostics presence.


















